Compugen presents COM701 ovarian cancer trial poster at ESMO

Go back to Compugen presents COM701 ovarian cancer trial poster at ESMO
Compugen Ltd (NASDAQ: CGEN) Delayed: 2.33 -0.09 (3.72%)
Previous Close $2.42    52 Week High $7.79 
Open $2.39    52 Week Low $4.32 
Day High $2.40    P/E N/A 
Day Low $2.33    EPS $-0.36 
Volume 138,414